This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Elsevier Announces The Launch Of Open Access Journal: Oral And Maxillofacial Surgery Cases

NEW YORK, July 28, 2014 /PRNewswire/ --

Elsevier, a world-leading provider of scientific, technical and medical information products and services, is pleased to announce the launch of Oral and Maxillofacial Surgery Cases , an open access, surgical journal.

The journal will publish case reports and case series that are prospective or retrospective and examine the outcomes of management in more than one patient. Cases may include new or modified methodology and treatment, uncommon findings, and mechanisms in oral and maxillofacial surgery cases.

Dr. Janice Lee, Deputy Clinical Director of the National Institute of Dental and Craniofacial Research at the NIH, and Editor-in-Chief of Oral and Maxillofacial Surgery Cases, explained, "I am pleased to work with Elsevier and the editorial board to provide this new resource to authors. We hope that this open access forum will offer stimulating, relevant, concise, and hypothesis-generating case reports and series."

Elizabeth Perill, Executive Publisher for Oral and Maxillofacial Surgery Cases at Elsevier said, "We see wonderful opportunities to better serve the oral and maxillofacial surgery community by publishing this open access case reports journal. Oral and Maxillofacial Surgery Cases will be a strong addition to Elsevier's open access journals."

For more information go to:

http://www.oralandmaxillofacialsurgerycases.com

http://www.journals.elsevier.com/oral-and-maxillofacial-surgery-cases

About Elsevier 

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions - among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey - and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world-leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact Natalie Hill-krasniqi Elsevier +44-20-7424-4404 n.hill-krasniqi@elsevier.com

SOURCE Elsevier

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,024.06 +183.54 1.03%
S&P 500 2,108.29 +22.78 1.09%
NASDAQ 5,005.3910 +63.9670 1.29%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs